Skip to content
  • Introduction |
    • Programs |
  • Purpose |
  • Dana |
  • Atypical PKAN |
    • What Is PKAN? |
  • Resources |
  • Donate |
  • Contact |
    • Board Of Directors |
      • Ronda Jones, Chair
      • Randy Jones, Vice Chair
      • Eileen Caldwell, Secretary
      • Frank Kearney, Treasurer
      • Paul T Willies, CEO |
    • PRIVACY POLICY & TERMS OF USE
  • Media |
DanaJonesBanner11

Resources |

To read more on PKAN CLICK HERE

grnball Overview of neurodegeneration with brain iron accumulation nbia disorders

grnball Case Report
Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration

CLINICAL TRIALS
Currently there are four clinical studies underway:

grnball Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

grnball A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

grnball Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration (TIRCON-EXT)

grnball Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

OTHER RESOURCES

(Clicking on these logos opens a new window)

nbia rareconnect tircon
nbiaworld nord rareRare Disease Day

Dana Renee Jones
March 25, 1985 ~ April 25, 2023 (age 38)
OBITUARY

The Celebration of Dana's life will be held Saturday, May 13 at 11:00 at First Baptist Mt. Juliet, receiving friends one hour prior to the celebration.


kroger
Kroger Community Rewards
Sign up today to benefit DJF every time you shop!
(Click HERE for details)


igive
guidestar
OFFICIAL ACCOUNTANTS
mckinley

facebook2
Copyright 2014-2023 - Dana Jones Foundation, Inc | PRIVACY POLICY & TERMS OF USE |
Registered with the Tennessee Secretary of State Division of Charitable Solicitations and Gaming REG # CO20079
Dana Jones Foundation, Inc. is a registered 501 (c)(3) Public Non-Profit organization – all donations are tax deductible with the IRS – FEIN # 46-2613758
Proudly powered by WordPress